Barinthus Biotherapeutics logo

Barinthus Biotherapeutics Employee Directory

Biotechnology ResearchEngland, United Kingdom11-50 Employees

Barinthus Biotherapeutics is a clinical-stage biotechnology company focused on developing T cell directed immunotherapies to address chronic infectious diseases, autoimmunity, and cancer. Its pipeline relies on four proprietary platform technologies and comprises five product candidates across multiple therapeutic areas. Notable candidates include VTP-300, intended as part of a functional cure approach for chronic HBV, VTP-1000 for celiac disease, and VTP-850 for recurrent prostate cancer.

Headquartered in Chilton, England, the company operates as a small to mid-sized biotechnology firm. In 2025, Barinthus Biotherapeutics completed a merger with Clywedog Therapeutics, forming a combined company. Its focus remains on advancing immunotherapies through clinical development to address infectious diseases, autoimmunity, and cancer.

Find Barinthus Biotherapeutics employees' phone numbers or email addresses

Barinthus Biotherapeutics Global Highlights

Location
Employees

Europe
28

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    27
  • Switzerland
    1

North America
14

Minus sign iconPlus sign icon
  • United States Of America
    14

Barinthus Biotherapeutics's Leadership

  • Chief Medical Officer at Barinthus Biotherapeutics
    L. H.
    Chief Medical Officer
  • Vice President Of Manufacturing at Barinthus Biotherapeutics
    S. A.
    Vice President Of Manufacturing
  • Chairman at Barinthus Biotherapeutics
    R. W. F. C.
    Chairman
  • Vice President, Corporate Development at Barinthus Biotherapeutics
    N. F.
    Vice President, Corporate Development
  • Vice President, Intellectual Property at Barinthus Biotherapeutics
    B. M.
    Vice President, Intellectual Property
  • Non Executive Director at Barinthus Biotherapeutics
    P. M.
    Non Executive Director
  • Director, Clinical Lead at Barinthus Biotherapeutics
    D. S.
    Director, Clinical Lead
  • Finance Director at Barinthus Biotherapeutics
    R. S.
    Finance Director

Barinthus Biotherapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Program & Project Management
  • Finance
  • Administrative
  • Engineering
  • Other
  • Quality Assurance
  • Operations
  • Biotechnology
  • Accounting
  • Business
  • Entrepreneurship
  • Business Development

Contact profiles from Barinthus Biotherapeutics

Name
Title
Contact
Location
Last Update
  • Chairman at Barinthus Biotherapeutics
    R. W. F. C.
    Chairman
    United Kingdom, England
    Sep 04, 2026
  • Chief Medical Officer at Barinthus Biotherapeutics
    L. H.
    Chief Medical Officer
    United Kingdom, England
    Jun 29, 2026
  • Vice President, Corporate Development at Barinthus Biotherapeutics
    N. F.
    Vice President, Corporate Development
    Apr 15, 2026
  • Vice President, Intellectual Property at Barinthus Biotherapeutics
    B. M.
    Vice President, Intellectual Property
    United Kingdom
    Apr 17, 2026
  • Vice President Of Manufacturing at Barinthus Biotherapeutics
    S. A.
    Vice President Of Manufacturing
    United Kingdom, England
    Oct 21, 2025
  • Non Executive Director at Barinthus Biotherapeutics
    P. M.
    Non Executive Director
    Switzerland, Vaud
    Sep 11, 2026
  • Director, Clinical Lead at Barinthus Biotherapeutics
    D. S.
    Director, Clinical Lead
    United Kingdom, England
    Jun 30, 2026
  • Finance Director at Barinthus Biotherapeutics
    R. S.
    Finance Director
    United Kingdom, England
    Apr 15, 2026
  • Director at Barinthus Biotherapeutics
    R. W.
    Director
    UNITED KINGDOM, Oxfordshire
    Oct 31, 2023
  • Human Resources Director at Barinthus Biotherapeutics
    T. R.
    Human Resources Director
    United Kingdom, England
    Sep 20, 2026

Frequently Asked Questions

What is Barinthus Biotherapeutics known for?

Minus sign iconPlus sign icon
Barinthus Biotherapeutics was founded in 2016 and operates in the Biotechnology Research industry. Explore Barinthus Biotherapeutics's company overview page for more information.

What is Barinthus Biotherapeutics's most common email format?

Minus sign iconPlus sign icon
Barinthus Biotherapeutics employees' email format typically follows the pattern of First.Last@vaccitech.co.uk. Trying to find reliable and up-to-date employee contact data? Find more Barinthus Biotherapeutics email formats with LeadIQ.

How many employees does Barinthus Biotherapeutics have currently?

Minus sign iconPlus sign icon
Barinthus Biotherapeutics has approximately 35 employees as of October 2026. These team members are located across 2 continents, including Europe and North America.

Who are Barinthus Biotherapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of October 2026, Barinthus Biotherapeutics's key employees include:

  • Chief Medical Officer: L. H.
  • Vice President Of Manufacturing: S. A.
  • Chairman: R. W. F. C.
  • Vice President, Corporate Development: N. F.
  • Vice President, Intellectual Property: B. M.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.